Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development

Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravacc has knowhow in vaccine conjugation ...

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services ...

Intravacc B.V.: Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

The 2025-2027 approval helps French innovators access Intravacc's vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...
Science Daily

New bacterial therapy destroys cancer without the immune system

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two harmonized bacteria to destroy tumors even in patients with weakened immune ...

Pfizer begins late-stage trial for new pneumococcal shot in infants after strong phase 2 data

Pfizer (PFE) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent ...
Science Daily

Scientists map how deadly bacteria evolved to become epidemic

Pseudomonas aeruginosa -- an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions -- evolved rapidly and then spread ...
The Guardian

A deadly bacterium is creeping up the US east coast. How worried should we be?

Warming ocean waters are priming beaches and raw shellfish for Vibrio even as scientists are trying to stay one step ahead Bailey Magers and Sunil Kumar cut strange figures on Pensacola Beach. Bags of ...